30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Renalytix PLC (RENX)

Track

Stock chart
Ticker: RENX Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
James McCullough
Chief Executive Officer
1 purchase — total 2,363 USD
Buy 12 Feb 2026
Value US$1,218,538.15 | Price 453.60 | Shares 49,849
Buy 11 Feb 2026
Value US$2,816,130.39 | Price 193.86 | Shares 76,805
Buy 11 Feb 2026
Value US$1,845,765.72 | Price 300.43 | Shares 63,142
Buy 11 Feb 2026
Value US$9,072.00 | Price 3.01 | Shares 3,010
Buy 20 Dec 2024
Value £2,437.50 | Price 0.10 | Shares 25,000
Buy 10 Dec 2024
Value £1,955.00 | Price 0.09 | Shares 23,000
Buy 10 Dec 2024
Value £4,450.00 | Price 0.09 | Shares 50,000
Buy 10 Dec 2024
Value £2,125.00 | Price 0.09 | Shares 25,000
Buy 9 Dec 2024
Value £4,000.00 | Price 0.08 | Shares 50,000
Buy 5 Dec 2024
Value £3,402.07 | Price 0.07 | Shares 48,601
Through Harwood Capital LLP, a closely affiliated person
Buy 5 Dec 2024
Value £3,997.50 | Price 0.08 | Shares 53,300
Buy 4 Dec 2024
Value £1,739.20 | Price 0.07 | Shares 23,989
Buy 8 Oct 2024
Value £45,000.00 | Price 0.09 | Shares 500,000
Through Harwood Capital LLP, a closely affiliated person
Sale 7 Oct 2024
Value £6,695.68 | Price 0.08 | Shares 83,696
Through Harwood Capital LLP, a closely affiliated person
Buy 8 Feb 2023
Value £311,737.50 | Price 0.90 | Shares 346,375
Through Harwood Capital LLP, a closely affiliated person
Sale 25 Jun 2021
Value £68,625.00 | Price 11.25 | Shares 6,100
Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited, a closely affiliated person
Sale 25 Jun 2021
Value £161,250.00 | Price 10.75 | Shares 15,000
Sale 18 Jun 2021
Value £192,999.99 | Price 11.35 | Shares 17,000
Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited, a closely affiliated person
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-12 B Purchase
3.3
James McCullough

Chief Executive Officer

Officer
49,849
453.60
US$1,218,538 		49,849 453.60 US$1,218,538
2026-02-13 2026-02-11 B Purchase
Joel Jung

interim Chief Financial Officer

Officer
76,805
193.86
US$2,816,130 		76,805 193.86 US$2,816,130
2026-02-12 2026-02-11 B Purchase
Joel Jung

interim Chief Financial Officer

Officer
63,142
300.43
US$1,845,766 		63,142 300.43 US$1,845,766
2026-02-12 2026-02-11 B Purchase
3.3
James McCullough

Chief Executive Officer

Officer
3,010
3.01
US$9,072 		3,010 3.01 US$9,072
2024-12-20 2024-12-20 B Purchase Fergus Fleming

Chief Technology Officer & Executive Director

Executive Director
25,000
0.10
£2,438 		25,000 0.10 £2,438
2024-12-11 2024-12-10 B Purchase
3.2
Julain Baines

Executive Chairman

Director
23,000
0.09
£1,955 		23,000 0.09 £1,955
2024-12-11 2024-12-10 B Purchase Howard Doran

President of Renalytix
50,000
0.09
£4,450 		50,000 0.09 £4,450
2024-12-11 2024-12-10 B Purchase
3.3
James McCullough

CEO

Officer
25,000
0.09
£2,125 		25,000 0.09 £2,125
2024-12-09 2024-12-09 B Purchase Howard Doran

President
50,000
0.08
£4,000 		50,000 0.08 £4,000
2024-12-11 2024-12-05 B Purchase Christopher Mills

Non-Executive Chairman, Chief Investment Officer

Through Harwood Capital LLP, a closely affiliated person Executive Director
48,601
0.07
£3,402 		48,601 0.07 £3,402
2024-12-06 2024-12-05 B Purchase
3.3
James McCullough

Chief Executive Officer

Officer
53,300
0.08
£3,998 		53,300 0.08 £3,998
2024-12-04 2024-12-04 B Purchase
3.2
Julian Baines

Executive Chairman

Director
23,989
0.07
£1,739 		23,989 0.07 £1,739
2024-10-11 2024-10-08 B Purchase Christopher Mills

Non-Executive Chairman, Chief Investment Officer

Through Harwood Capital LLP, a closely affiliated person Executive Director
500,000
0.09
£45,000 		500,000 0.09 £45,000
2024-10-11 2024-10-07 S Sale Christopher Mills

Non-Executive Chairman, Chief Investment Officer

Through Harwood Capital LLP, a closely affiliated person Executive Director
83,696
0.08
£6,696 		83,696 0.08 £6,696
2023-02-10 2023-02-08 B Purchase Christopher Mills

Non-Executive Chairman

Through Harwood Capital LLP, a closely affiliated person Executive Director
346,375
0.90
£311,738 		346,375 0.90 £311,738
2021-06-28 2021-06-25 S Sale Christopher Mills

Chief Executive Officer

Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited, a closely affiliated person Executive Director
6,100
11.25
£68,625 		6,100 11.25 £68,625
2021-06-25 2021-06-25 S Sale Fergus Fleming

Chief Technology Officer

Officer
15,000
10.75
£161,250 		15,000 10.75 £161,250
2021-06-22 2021-06-18 S Sale Christopher Mills

non-exec director and Interim Chair

Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited, a closely affiliated person Executive Director
17,000
11.35
£193,000 		17,000 11.35 £193,000
Explore more

More insider trading research around Renalytix PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America